| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Vvi1g0032 | ATGAGATGGGATTGTGGCTTTTGTAAAACCCTAGCTTGGTTGGATCTGTTGTTTCTCTTCTGCGTTTTTTTTTCGGTTTATGGAAGGGTGTTTTCGGGGGAAGTGGTTTCCGAGAGGGAGATTCTTCTCGAATTCAAGAGCTCAGTGTCTGATCCGTATGGGGTTCTGTCCAGCTGGAGCTCAGAGAACTTGGATCACTGTTCTTGGGCCGGCATCTCCTGCGACTCCAATTCTAGGTTTCCGTTTCATGGTTTTGGAATCAGAAGGGATTGTTTTAATGGGAGTGGGAGGTTGGTCGGAGAACTGTCTCCGGTGGTCTCGAAACTCACTGAACTTAGGATTTTTTCGCTTCCTTTTCATGAATTTAGTGGTGAAATTCCTAATGAAATATGGGGTTTAGAAAAGTTAGAGGTACTTGATCTTGAGGGCAATGCATTTACCGGAAATTTGCCTGGCGAATTCTCTGGTTTGAGGAAATTGCAGGTGTTAAACCTTGGATTTAATATAATTGCTGGGGAGATTCCGTTTTCACTGTCAAATTGTGTTAATTTGCGGATTTTGAATTTAGCTGGGAATGAAGTGAACGGAAGAATTCCAGGGTTTATTGGTAGTTTTCCCAAGTTACAGGGGCTTTATTTGTCTCACAATGGGATGATTGGAACAGTTCCGAGCTTGGGGAATTGTAGACGGTTACGAACACTTTTGTTGTTCTCAAATAAGTTTGATGATGTCATTCCTCGTGAGCTCGGTCGTCTGCGGAAGCTTGAGGTTCTAGATTTTGATACCGCTGATGATAAAAATCATTTCCAAGGTTCCATTCCTATGGAAATTACAACCCTTCCAAAGCTAAGACTACTGTGGGCGCCTAGGGCAACACTTGAAGGCAAGTTTCCCAGCAATTGGGGCACTTGCAGCAGCTTGGAAATGCAGACTGAATATGCGTTTCTTGCTGGTGGGAATAGACTCTTTGGATCTTTTCCTGGAAACTTCTTTGGACAATGCAACAGATTGAATGGATTGCTCGTTAATGTCAGCGACAACCGGATATCTGGTGTGTTAGAGACTGGTACAATCTGCAGATCTCTTAAGTTTTTGGATGTCTCTAAGAACCAGATTTCTGGTTCAATACCTCGAGGTCTTGGAGATTTGCAATCTCTCATTGTTCTTGATTTGAGTGGGAACAAATTGCAAGGTCAGATTCCTGTGGAGCTTGGCCAGCTGAAGTATCTTAAGTATCTGTCTTTGGCTGGTAACAACCTTACTGGTGGCATCCCTTCTAGTTTCAAACATGTACGCTCTCTTGAGGTGTTAGAACTTTCTTCAAACTCTCTGTCTGGTGAGATTCCACAAGGTCTTGTAGAGTTGAGAAACCTAACTGTTCTTCTGCTCAACAACAATGAACTCTCGGGACCGATTCTCTCTGATTTGACTCAAGTGAAATCACTCTCTGCATTTAATGCATCCTTTAATGACTTGTCTGGACGATCACAGTTGGACAACAATGTGATGCTTGGAAGTCCTTCTCATCATTCTGGCCACAGGCATTTCCTAGCTGAGCAGTCTTTGGATCATTCAAAGAGCAATGGGAGTTCAGCCACTCCATTACAAAGTTCTTCTGAAGATGATGATGATGATGATGGGCTCAGTTCTATTGAGATTGCATCCATAATTTCTGCATCTGCTATTTTTTCTGTTCTTGTGGCTTTGCTCGTTCTCTTCTTTTACACGAGAAAATGGATCCCCAAGTCCCGGGTTCAGGGTTCTGAGACAAGGGAAATTACAGTTTTCACTGATATTGGTGTTCCATTGACATTTGAGAATATAGCTTGGGCAACTGGGAATTTCAATGCCAGCAACTGCATTGGGAATGGAGGTTTTGGTGCCACTTATAAGGCTGAGATTTCACCAGGAGCCCTAGTGGCTGTGAAGAGACTGGCTGTTGGGAGGTTCACTCAAGGTGTTCAGCAGTTTCATGCAGAGGTTAAAACCCTTGGAAGGATTCGACACCCAAATCTCGTAACTTTAATAGGTTACCATGCTAGTAAAACAGAGATGTTCCTGATATACAATTATTTGCCTGGTGGTAATTTGGAAAATTTTATCCAGGAAAGATCTGCAACAGCTGTTAATTGGAAGATTCTTCACAAGATTGCTTTGCATATAGCCAGTGCACTTGCATATCTGCATGACCAATGTAGTCCACGGGTCCTCCACCGTGATGTCAAGCCTAGTAATATCTTGTTGGATAATGACTTTAATGCTTATTTGTCAGACTTTGGATTATCTAGGCTATTGGGGACTTCTGAAACACATGCAACAACTGGTGTGGCAGGAACATTTGGGTATGTAGCTCCAGAATATGCTATGACTTGTCGTGTGTCCGAGAAGGCTGATGTTTACAGCTATGGTGTAGTGCTCCTTGAGCTGATTTCAGATAAGAAAGCATTGGACCCTTCATTTTCTTCACATGCAAATGGCTTCAACATTGTTTCATGGGCATGCATGCTATTGCGGCAGGGTCAGGCGAAGGATGTTTTCAATGAAAGGCTATGGGATTCAGGTCCTCATGATAACCTGGTAGATGTACTTCATTTGGCTGTTATGTGCACTGTTGAGTCATTCTCCATCAGGCCAACCATGAAGCGGGTAGTGCAACGGTTGAAACAACTGCAGCCGCCCTCAAACTAG | 2688 | 0.4323 | MRWDCGFCKTLAWLDLLFLFCVFFSVYGRVFSGEVVSEREILLEFKSSVSDPYGVLSSWSSENLDHCSWAGISCDSNSRFPFHGFGIRRDCFNGSGRLVGELSPVVSKLTELRIFSLPFHEFSGEIPNEIWGLEKLEVLDLEGNAFTGNLPGEFSGLRKLQVLNLGFNIIAGEIPFSLSNCVNLRILNLAGNEVNGRIPGFIGSFPKLQGLYLSHNGMIGTVPSLGNCRRLRTLLLFSNKFDDVIPRELGRLRKLEVLDFDTADDKNHFQGSIPMEITTLPKLRLLWAPRATLEGKFPSNWGTCSSLEMQTEYAFLAGGNRLFGSFPGNFFGQCNRLNGLLVNVSDNRISGVLETGTICRSLKFLDVSKNQISGSIPRGLGDLQSLIVLDLSGNKLQGQIPVELGQLKYLKYLSLAGNNLTGGIPSSFKHVRSLEVLELSSNSLSGEIPQGLVELRNLTVLLLNNNELSGPILSDLTQVKSLSAFNASFNDLSGRSQLDNNVMLGSPSHHSGHRHFLAEQSLDHSKSNGSSATPLQSSSEDDDDDDGLSSIEIASIISASAIFSVLVALLVLFFYTRKWIPKSRVQGSETREITVFTDIGVPLTFENIAWATGNFNASNCIGNGGFGATYKAEISPGALVAVKRLAVGRFTQGVQQFHAEVKTLGRIRHPNLVTLIGYHASKTEMFLIYNYLPGGNLENFIQERSATAVNWKILHKIALHIASALAYLHDQCSPRVLHRDVKPSNILLDNDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAMTCRVSEKADVYSYGVVLLELISDKKALDPSFSSHANGFNIVSWACMLLRQGQAKDVFNERLWDSGPHDNLVDVLHLAVMCTVESFSIRPTMKRVVQRLKQLQPPSN* | 896 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Vvi1g0032 | 895 | Gene3D | Ribonuclease Inhibitor | 400 | 512 | IPR032675 | - | |
| Vvi1g0032 | 895 | Gene3D | Ribonuclease Inhibitor | 35 | 198 | IPR032675 | - | |
| Vvi1g0032 | 895 | MobiDBLite | consensus disorder prediction | 523 | 537 | - | - | |
| Vvi1g0032 | 895 | PANTHER | LRR RECEPTOR-LIKE SERINE/THREONINE-PROTEIN KINASE-RELATED | 23 | 889 | - | - | |
| Vvi1g0032 | 895 | FunFam | LRR receptor-like serine/threonine-protein kinase RPK2 | 579 | 691 | - | - | |
| Vvi1g0032 | 895 | FunFam | LRR receptor-like serine/threonine-protein kinase GSO1 | 261 | 522 | - | - | |
| Vvi1g0032 | 895 | SUPERFAMILY | Protein kinase-like (PK-like) | 593 | 887 | IPR011009 | - | |
| Vvi1g0032 | 895 | FunFam | LRR receptor-like serine/threonine-protein kinase RPK2 | 35 | 202 | - | - | |
| Vvi1g0032 | 895 | SMART | serkin_6 | 615 | 894 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi1g0032 | 895 | Gene3D | Transferase(Phosphotransferase) domain 1 | 692 | 892 | - | - | |
| Vvi1g0032 | 895 | MobiDBLite | consensus disorder prediction | 523 | 546 | - | - | |
| Vvi1g0032 | 895 | CDD | STKc_IRAK | 621 | 890 | - | - | |
| Vvi1g0032 | 895 | ProSiteProfiles | Protein kinase domain profile. | 615 | 895 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi1g0032 | 895 | FunFam | LRR receptor-like serine/threonine-protein kinase RPK2 | 692 | 895 | - | - | |
| Vvi1g0032 | 895 | Pfam | Protein kinase domain | 618 | 821 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Vvi1g0032 | 895 | Pfam | Leucine rich repeat | 409 | 468 | IPR001611 | GO:0005515 | |
| Vvi1g0032 | 895 | SMART | LRR_typ_2 | 431 | 455 | IPR003591 | - | |
| Vvi1g0032 | 895 | SMART | LRR_typ_2 | 133 | 156 | IPR003591 | - | |
| Vvi1g0032 | 895 | SMART | LRR_typ_2 | 157 | 181 | IPR003591 | - | |
| Vvi1g0032 | 895 | SMART | LRR_typ_2 | 383 | 407 | IPR003591 | - | |
| Vvi1g0032 | 895 | Gene3D | Ribonuclease Inhibitor | 199 | 399 | IPR032675 | - | |
| Vvi1g0032 | 895 | Pfam | Leucine rich repeat N-terminal domain | 37 | 75 | IPR013210 | - | |
| Vvi1g0032 | 895 | Gene3D | Phosphorylase Kinase; domain 1 | 578 | 691 | - | - | |
| Vvi1g0032 | 895 | ProSitePatterns | Protein kinases ATP-binding region signature. | 621 | 643 | IPR017441 | GO:0005524 | |
| Vvi1g0032 | 895 | SUPERFAMILY | RNI-like | 101 | 494 | - | - | |
| Vvi1g0032 | 895 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 736 | 748 | IPR008271 | GO:0004672|GO:0006468 |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Vvi1g0032 | Vvi-Chr1 | 442128 | 445496 | Dispersed/Transposed |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Vvi1g0032 | 119 | 894 | Receptor kinase-like Gene Family | AT3G02130 | 55.915 | 0.0 | 761 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_LRR-XV | Vvi1g0032 | Pkinase | 1e-43 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Vvi1g0032 | - | - | vvi:100854554 | 1129.78 |